Cost-effectiveness of elective cesarean delivery in human immunodeficiency virus-infected women

Keyphrases

• AIDS/HIV 100%
• Cost-effectiveness 100%
• Elective Cesarean 100%
• Virus Transmission 50%
• Cost Savings 40%
• Delivery Strategy 40%
• Zidovudine 30%
• Usual Care 20%
• Perinatal Transmission 20%
• Transmission Rate 20%
• Viral Load 10%
• United States 10%
• Pregnant Women 10%
• Pediatric 10%
• Management Strategy 10%
• Health Care Costs 10%
• Mode of Delivery 10%
• Human Immunodeficiency Virus Infection 10%
• Cesarean Delivery 10%
• Combined Antiretroviral Therapy (cART) 10%
• Payer Perspective 10%
• Third-party Payers 10%
• Overall Cost 10%
• Health Strategy 10%
• Decision-analytic Model 10%
• Delivery Cost 10%

Medicine and Dentistry

• Human Immunodeficiency Virus 100%
• Cesarean Section 100%
• Cost-Effectiveness Analysis 100%
• Health Care Cost 60%
• Virus Transmission 50%
• Zidovudine 30%
• Human Immunodeficiency Virus Infection 10%
• Medical Care 10%
• Pediatrics 10%
• Antiretroviral Therapy 10%
• Lifespan 10%
• Pregnant Woman 10%